Activity of MK-8504 in Anti-retroviral-naïve, Human Immunodeficiency Virus 1 (HIV-1) Infected Participants (MK-8504-002)
Clinical trial NCT03188523 · COMPLETED
Trial details
- NCT number
- NCT03188523
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-08
- Primary completion
- 2018-05-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.